Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.

t(8;21) and t(16;21) create two fusion proteins, AML-1-ETO and AML-1-MTG16, respectively, which fuse the AML-1 DNA binding domain to putative transcriptional corepressors, ETO and MTG16. Here, we show that distinct domains of ETO contact the mSin3A and N-CoR corepressors and define two binding sites within ETO for each of these corepressors. In addition, of eight histone deacetylases (HDACs) tested, only the class I HDACs HDAC-1, HDAC-2, and HDAC-3 bind ETO. However, these HDACs bind ETO through different domains. We also show that the murine homologue of MTG16, ETO-2, is also a transcriptional corepressor that works through a similar but distinct mechanism. Like ETO, ETO-2 interacts with N-CoR, but ETO-2 fails to bind mSin3A. Furthermore, ETO-2 binds HDAC-1, HDAC-2, and HDAC-3 but also interacts with HDAC-6 and HDAC-8. In addition, we show that expression of AML-1-ETO causes disruption of the cell cycle in the G(1) phase. Disruption of the cell cycle required the ability of AML-1-ETO to repress transcription because a mutant of AML-1-ETO, Delta469, which removes the majority of the corepressor binding sites, had no phenotype. Moreover, treatment of AML-1-ETO-expressing cells with trichostatin A, an HDAC inhibitor, restored cell cycle control. Thus, AML-1-ETO makes distinct contacts with multiple HDACs and an HDAC inhibitor biologically inactivates this fusion protein.

Pubmed ID: 11533236 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Binding Sites | Cell Line | Core Binding Factor Alpha 2 Subunit | DNA-Binding Proteins | Enzyme Inhibitors | Histone Deacetylase Inhibitors | Histone Deacetylases | Hydroxamic Acids | Leukemia, Myelomonocytic, Acute | Mice | Models, Genetic | Molecular Sequence Data | Nuclear Proteins | Nuclear Receptor Co-Repressor 1 | Oncogene Proteins, Fusion | Protein Structure, Tertiary | Proto-Oncogene Proteins | Repressor Proteins | Sequence Homology, Amino Acid | Transcription Factors | Transcription, Genetic | Translocation, Genetic

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: R01 CA077274
  • Agency: NCI NIH HHS, Id: P01 CA071907
  • Agency: NCI NIH HHS, Id: P01 CA71907
  • Agency: NCI NIH HHS, Id: R01-CA77274
  • Agency: NIA NIH HHS, Id: R01-AG13726
  • Agency: NCI NIH HHS, Id: R01-CA76186
  • Agency: NCI NIH HHS, Id: P30 CA068485
  • Agency: NCI NIH HHS, Id: CA68485
  • Agency: NCI NIH HHS, Id: R01-CA64140
  • Agency: NCI NIH HHS, Id: R01 CA064140

BioGRID (Data, Interactions)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.